3-Hydroxy-2-methylpyridine | CAS:1121-25-1

We serve 3-Hydroxy-2-methylpyridine CAS:1121-25-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Hydroxy-2-methylpyridine

Chemical Name:3-Hydroxy-2-methylpyridine
CAS.NO:1121-25-1
Synonyms:3-Hydroxy-2-methylpyridine
2-methyl-3-hydroxypyridine
2-methylpyridin-3-ol
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 287.1±20.0 °C at 760 mmHg
Melting Point 168-169 °C(lit.)
Molecular Formula C6H7NO
Molecular Weight 109.126
Flash Point 127.4±21.8 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.551
 
Specification:
Appearance:Light brown crystalline powder
Assay:≥95.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 3-Hydroxy-2-methylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-methylpyridin-3-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methyl-3-hydroxypyridine Use and application,2-methylpyridin-3-ol technical grade,usp/ep/jp grade.


Related News: US citizens who have been to China in the last 14 days need to re-book to one of seven gateway airports: John F. Kennedy International Airport in New York, Los Angeles International Airport, Seattle, San Francisco International Airport, Chicago, Atlanta and Honolulu.4-bromoanisole manufacturer This is how an API becomes a medicine.2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile supplier This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?Bis(2-chloroethyl)amine hydrochloride vendor Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.A 40-year-old Chinese woman also tested positive. She was already in quarantine as she is related to another patient who contracted the virus.